PFE - J&J Bristol Myers latest to lose bids to halt Medicare price negotiations
2024-04-30 09:49:06 ET
More on Bristol-Myers, Johnson & Johnson, etc.
- Bristol Myers Squibb: Tough Times Continue
- Bristol-Myers Squibb Company (BMY) Q1 2024 Earnings Call Transcript
- Bristol-Myers Squibb Stock: Gloomy Q1 Earnings Trigger Justified Sell-Off
- EU regulators recommend full approval for J&J TB drug Sirturo
- Bristol Myers, Repertoire to develop tolerizing vaccines in multi-year pact